J-f F. Dufour

Bern, BE, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Screening for hepatocellular carcinoma among adults with HIV/HBV co-infection in Zambia: a pilot study.

Screening for hepatocellular carcinoma among adults with HIV/HBV co-infection in Zambia: a pilot study.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: April 23, 2021

Trends in hepatitis C-related mortality in Switzerland.

Trends in hepatitis C-related mortality in Switzerland.

Journal: Journal of viral hepatitis

Published: May 15, 2017

Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference.

Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference.

Journal: Alimentary pharmacology & therapeutics

Published: June 17, 2016

Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29).

Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29).

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: November 28, 2015

Open-label study of faldaprevir plus peginterferon and ribavirin in hepatitis C virus genotype 1-infected patients who failed placebo plus peginterferon and ribavirin.

Open-label study of faldaprevir plus peginterferon and ribavirin in hepatitis C virus genotype 1-infected patients who failed placebo plus peginterferon and ribavirin.

Journal: Journal of viral hepatitis

Published: July 20, 2015

CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation.

CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation.

Journal: The pharmacogenomics journal

Published: April 07, 2015

T- and B-cell responses and previous exposure to hepatitis B virus in 'anti-HBc alone' patients.

T- and B-cell responses and previous exposure to hepatitis B virus in 'anti-HBc alone' patients.

Journal: Journal of viral hepatitis

Published: January 14, 2015

Separation of small metabolites and lipids in spectra from biopsies by diffusion-weighted HR-MAS NMR: a feasibility study.

Separation of small metabolites and lipids in spectra from biopsies by diffusion-weighted HR-MAS NMR: a feasibility study.

Journal: The Analyst

Published: November 05, 2014

Impact of common risk factors of fibrosis progression in chronic hepatitis C.

Impact of common risk factors of fibrosis progression in chronic hepatitis C.

Journal: Gut

Published: February 19, 2014

Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.

Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.

Journal: Journal of hepatology

Published: November 11, 2013

Intermediate hepatocellular carcinoma: current treatments and future perspectives.

Intermediate hepatocellular carcinoma: current treatments and future perspectives.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: May 30, 2013

The number needed to treat to prevent mortality and cirrhosis-related complications among patients with cirrhosis and HCV genotype 1 infection.

The number needed to treat to prevent mortality and cirrhosis-related complications among patients with cirrhosis and HCV genotype 1 infection.

Journal: Journal of viral hepatitis

Published: May 17, 2013

Showing 1-12 of 24

Last Updated: 09/26/2026